Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Growth in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Rating) was the target of a large growth in short interest in December. As of December 30th, there was short interest totalling 500 shares, a growth of 400.0% from the December 15th total of 100 shares. Based on an average daily trading volume, of 2,900 shares, the short-interest ratio is currently 0.2 days.

Hikma Pharmaceuticals Stock Performance

Hikma Pharmaceuticals stock opened at $42.85 on Wednesday. The firm has a 50-day moving average price of $37.10 and a 200-day moving average price of $34.83. Hikma Pharmaceuticals has a 12-month low of $25.12 and a 12-month high of $58.32.

About Hikma Pharmaceuticals

(Get Rating)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded.

Featured Articles

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.